+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 6Years - 12Years
All Genders
ID06860763

Clinical Study on Acupuncture Treatment for Attention Deficit Hyperactivity Disorder

Led by The Third Affiliated Hospital of Beijing University of Chinese Medicine · Updated on 2025-12-19

76

Participants Needed

1

Research Sites

6 weeks

Total Duration

On this page

Sponsors

T

The Third Affiliated Hospital of Beijing University of Chinese Medicine

Lead Sponsor

M

Mahidol University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the potential benefits of acupuncture as a treatment for children aged 6 to 12 years with Attention Deficit Hyperactivity Disorder ADHD. It compares acupuncture combined with traditional Chinese herbal treatment to herbal treatment alone, using a mixed-methods approach that includes data mining, treatment outcome assessments, and patient perspectives. The study seeks to provide a detailed understanding of acupunctures role in managing ADHD symptoms, executive function, quality of life, and sleep quality. Participants will be assigned to either an experimental group receiving acupuncture alongside herbal medicine or a control group receiving only the herbal treatment based on Chinese Medicine clinical guidelines. Acupuncture treatments involve specific needles and techniques informed by prior data analysis of effective acupoints for ADHD. Herbal treatments follow established clinical guidelines for pediatric ADHD. The study includes three phases acupoint data mining, clinical intervention with repeated assessments, and qualitative interviews with children, caregivers, and clinicians. During the 12-month study, children will undergo quantitative assessments such as the SNAP-IV, Conners 3-P, BRIEF-2, PedsQL 4.0, PSQI, and CGI at baseline, post-treatment, and follow-up points to measure ADHD symptoms and related impacts. Qualitative interviews will explore treatment experiences and satisfaction. Researchers will analyze changes in symptoms, executive function, quality of life, and sleep, combining statistical methods with thematic analysis. The study starts in October 2024 and is expected to complete by May 2026.

CONDITIONS

Brief Title

Acupuncture for ADHD: Acupoint Data Mining, Clinical Effectiveness, and Interviews to Explore Treatment Outcomes.

Who Can Participate

Age: 6Years - 12Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Confirmed ADHD diagnosis based on DSM-5 criteria and Chinese Medicine clinical guidelines
  • Age between 6 and 12 years
  • No use of other pharmacological treatments within 2 weeks before the study
  • IQ score greater than 80 by Raven's Progressive Matrices test
  • No participation in other clinical trials
Not Eligible

You will not qualify if you...

  • Not meeting inclusion criteria
  • Comorbid psychiatric disorders or severe medical conditions affecting the study (e.g., epilepsy, severe anxiety)
  • Pervasive developmental disorders or intellectual disability
  • History of suicidal or self-harming behavior
  • Participation in other drug clinical trials within past 3 months
  • Severe cardiovascular, hepatic, renal, or hematologic diseases
  • Any other condition that may interfere with treatment assessment or safety

Research Team

T

Tananan Sangwanit, Ph.D.student

X

Xue Bai, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here